A
397030
vs
K
KOSPI 200
Over the past 12 months, AprilBio Co Ltd has significantly outperformed KOSPI 200, delivering a return of +304% compared to the KOSPI 200's +108% growth.
Stocks Performance
397030 vs KOSPI 200
Performance Gap
397030 vs KOSPI 200
Performance By Year
397030 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
AprilBio Co Ltd
Glance View
AprilBio Co Ltd is a Korea-based company primarily engaged in the biological drug development business. The Company is primarily engaged in the bio-innovative new drug research and development (R&D) business such as antibody therapeutics and long-acting recombinant protein pharmaceuticals.